Number of patients | 54 |
Male/female (%) | 56/44 |
Age (months) | 3.3 (1.7–12.3) |
  < 12 months (%) | 75.9 |
 12–24 months | 3.7 |
  > 24 months | 20.4 |
Weight (kg) | 6 (4.5–9.1) |
PRISM II (24 h) score | 14 (11–17) |
Pulmonary admission diagnosis (%) | 87.1 |
PARDS (%) | 81.5 |
 Mild (%) | 15.9 |
 Moderate (%) | 59.1 |
 Severe (%) | 25.0 |
PIP (cmH2O) | 31 (30–34) |
PEEP (cm H2O) | 8 (6–8) |
FiO2 | 0.5 (0.4–0.76) |
SpO2/FiO2 ratio on CMV | 190 (121–243) |
OI on CMV | 10.2 (8.3–15.7) |
pH | 7.3 (7.23–7.35) |
pCO2 on CMV (mmHg) | 57 (52–64) |
Duration of MV (days) | 6.6 (4.9–10.4) |
Extra-corporeal membrane support (%) | 1.9 |
Mortality (%) | 1.9 |